Life Healthcare Group Limited informed the shareholders and investors that, based on the information currently available, the loss attributable to Shareholders for the six months ended 30 September 2018 is expected to increase by approximately 55% to approximately 75% as compared with that for the six months ended 30 September 2017. Such increase was mainly attributable to the impairment loss on interest in an associate engaging in research and development of genetic testing services, the property, plant and equipment and intangible asset to reflect the change in its operating status, legal and professional fees related to project investment activities; and the increase in selling, distribution costs and administrative expenses as a result of the increase in marketing and promotion expenses from the healthcare services business, which was partially offset by the increase in gross profit generated from the Group's healthcare services business.